Genentech drug boosts leukemia patient survival (Reuters)

[riky]

Genentech drug boosts leukemia patient survival
    (Reuters)

 

Reuters - A combination of Genentech Inc's cancer drug Rituxan and chemotherapy reduces by 41 percent the risk of death or cancer progression, compared with chemotherapy alone, for patients with a common form of leukemia, the company said on Saturday.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20081206/hl_nm/us_genentech_leukemia